ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,436Medicare Part D Prescriptions Filled, Including Refills

Rank: 987 out of 3647

$353K Total Retail Price of All Prescriptions

Rank: 1722 out of 3647

527 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

11% of this provider’s 527 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 8,818 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$37 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
AMLODIPINE BESYLATE 615 579 1 2
SIMVASTATIN 448 419 2 1
LISINOPRIL 409 400 3 4
OMEPRAZOLE 325 315 4 3
HYDROCHLOROTHIAZIDE 315 297 5 9
ATENOLOL 285 279 6 10
LOSARTAN POTASSIUM 277 265 7 11
METFORMIN HCL 246 237 8 6
PROAIR HFA 246 239 8 62
CLONIDINE HCL 242 236 10 46
RANITIDINE HCL 239 219 11 29
WARFARIN SODIUM 236 217 12 15
METOPROLOL TARTRATE 186 171 13 7
FUROSEMIDE 172 155 14 8
VIAGRA 165 162 15 69
POTASSIUM CHLORIDE 130 121 16 24
TEMAZEPAM 128 111 17 47
LEVOTHYROXINE SODIUM 127 118 18 5
ATORVASTATIN CALCIUM 108 107 19 13
LOVASTATIN 108 108 19 21
ALENDRONATE SODIUM 106 105 21 23
ACETAMINOPHEN-CODEINE 104 78 S3 22 149
FLUTICASONE PROPIONATE 103 90 23 32
AMOXICILLIN 103 90 23 133
IBUPROFEN 103 83 23 55
TAMSULOSIN HCL 96 93 26 28
GLIPIZIDE 95 90 27 41
ALLOPURINOL 92 85 28 37
NOVOLIN 70-30 87 86 29 130
IRBESARTAN 86 75 30 232
LOSARTAN-HYDROCHLOROTHIAZIDE 85 84 31 48
AVAPRO 77 70 32 315
NIFEDIPINE ER 76 68 33 67
LANTUS 76 70 33 59
GLYBURIDE-METFORMIN HCL 74 65 R 35 94
ALPRAZOLAM 73 73 36 31
DOXAZOSIN MESYLATE 72 72 37 57
DICLOFENAC SODIUM 71 64 38 86
PLAVIX 69 64 39 39
TRIAMTERENE-HCTZ 61 61 40 58
HYDRALAZINE HCL 57 57 41 81
MELOXICAM 56 55 42 33
METOPROLOL SUCCINATE 53 53 43 18
HYDROCODONE-ACETAMINOPHEN 50 45 S3 44 12
DONEPEZIL HCL 50 50 44 30
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 13, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.